Navellier & Associates’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
7,222
-205
-3% -$8.09K 0.03% 292
2025
Q4
$339K Sell
7,427
-3,207
-30% -$143K 0.04% 262
2025
Q3
$450K Buy
+10,634
New +$401K 0.05% 273

Other funds holding AORT

Navellier & Associates's AORT Position: Q1 2026 in Review

Navellier & Associates reduced its Artivion (AORT) stake by 2.8% in Q1 2026, selling an estimated $8.09K and leaving 7,222 shares worth $264K. The position accounts for 0.03% of the portfolio, ranked #292.

Navellier & Associates first reported a position in AORT in Q3 2025 and has held it in 3 quarters since. The position peaked at $450K in Q3 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Navellier & Associates held 7,222 shares of Artivion worth $264K as of Q1 2026.
  • Navellier & Associates sold 205 Artivion shares in Q1 2026, an estimated $8.09K.
  • Artivion made up 0.03% of Navellier & Associates's portfolio in Q1 2026, its #292 holding.
  • Navellier & Associates first reported a position in Artivion in Q3 2025 and has held it in 3 quarters since.
  • Navellier & Associates's Artivion position peaked at $450K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.